TherapeuticsMD TXMD
NASDAQ TXMD
$1.90 +0.02 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Divestments (2011)

Updated

TherapeuticsMD's Divestments was $22.63 million in Q2 2022, down 81.1% from the prior quarter.

Analysis

TherapeuticsMD (TXMD) Divestments (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 62.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 TherapeuticsMD 21.67 Mn 21.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 607,000.00
Mar 31, 2011 100,000.00
API Access

TherapeuticsMD Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=TXMD&period=max&api_key=YOUR_API_KEY